General pharmacologic treatment of acute myocardial infarction (Q28184207)

Europe PubMed Central

title

General pharmacologic treatment of acute myocardial infarction (English)

0 references

main subject

myocardial infarction

1 reference

acute myocardial infarction

inferred from title

1 reference

A W Shannon

1

0 references

R A Harrigan

series ordinal

2

0 references

language of work or name

English

0 references

publication date

May 2001

0 references

published in

Emergency medicine clinics of North America

0 references

volume

19

0 references

issue

2

0 references

page(s)

417-31

0 references

cites work

Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Beneficial actions of nitrates in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Recent antiplatelet drug trials in the acute coronary syndromes. Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT.

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Beta blockers: evidence versus wishful thinking

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Platelet glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Infarct size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies.

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Evolution of the management of acute myocardial infarction: a 20th century saga.

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Antithrombotic agents in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Viagra, the latest cardio-VASCULAR drug

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

The results of CAPRIE, IST and CAST. Clopidogrel vs. Aspirin in Patients at Risk of Ischaemic Events. International Stroke Trial. Chinese Acute Stroke Trial.

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

A comparison of metoprolol and morphine in the treatment of chest pain in patients with suspected acute myocardial infarction--the MEMO study

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Clinical safety and efficacy of clopidogrel-Implications of the clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE) study for future management of atherosclerotic disease

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

New antiplatelet agents for acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Abciximab. An updated review of its use in ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Prospective use of glycoprotein IIb/IIIa receptor blockers in the emergency department setting

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Prospects for therapy of nitrate tolerance

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Update on aspirin in the treatment and prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Effect of nitrates on myocardial remodeling after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Comparison of Atrial Natriuretic Peptide Versus Nitroglycerin for Reducing Blood Pressure in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Use of oral sildenafil (Viagra) in the treatment of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Reduction of infarct size by oxygen inhalation following acute coronary occlusion

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Tirofiban. A review of its use in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Do ACE Inhibitors Provide Protection for the Heart in the Clinical Setting of Acute Myocardial Infarction?

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Randomised trial of oral morphine for chronic non-cancer pain

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Low molecular weight heparin(oid)s. Clinical investigations and practical recommendations

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Nitrate Therapy for Stable Angina Pectoris

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

ACE inhibitors in acute myocardial infarction: patient selection and timing

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

The role of magnesium therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Pharmacologic therapies after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Adjunctive therapy in the management of patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Therapy for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Emergency Department Use of Aspirin in Patients with Possible Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Platelet GPIIb-IIIa blockers

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021

Unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016/S0733-8627(05)70192-9

7 January 2021